Additional Metadata
Keywords blue-light therapy, calcipotriol and betamethasone dipropionate gel, cost-effectiveness, Dovobet®, mild-to-moderate psoriasis
Persistent URL dx.doi.org/10.2217/cer-2017-0007, hdl.handle.net/1765/101095
Journal Journal of Comparative Effectiveness Research
Note no subscription
Citation
Ansaripour, A, Thio, H.B, Maessen, R. (Rob), & Redekop, W.K. (2017). The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis. Journal of Comparative Effectiveness Research, 6(4), 325–335. doi:10.2217/cer-2017-0007